In breast cancer, it has been reported that radiation or endocrine therapy upregulates ERBB2 gene transcription in HER2-low or HER2-negative subtypes, leading to treatment resistance (Liu et al., 2018; Duru et al., 2012; Cao et al., 2009). The gene discussed is ERBB2; the disease is breast carcinoma.